Deep Science Ventures
Co-founder & CEO, AI for predictable drug discovery and development
Get notified of more jobs like this · No spam, ever
How your CV stacks up
Upload your CV to see how well it fits this job role
?%
Co-founder & CEO – Drug Discovery AI Platform (Spin-out from Deep Science Ventures)
Join us to build the company that makes AI do the reasoning work of drug discovery—so a small team can achieve the research output of a large one.
We are seeking an experienced founder and operator to partner with our two technical founders as Co-founder & CEO, guiding our platform—a spin-out from Deep Science Ventures—through a competitive seed round, Series A, and beyond.
The Opportunity
Drug discovery remains fundamentally constrained by human cognition and siloed information. Progress relies on researchers manually sidestepping limiting factors:
- Ability to read and connect vast datasets across fragmented teams
- Capacity to hold complex hypotheses in memory
- Speed of validating new ideas—bounded by the pace at which human intuition can test them
It’s one of the world’s most critical unresolved challenges—and one of the least scalable.
"Doing the reasoning work"
We’re building the AI that replaces rigorous human reasoning at scale. Our platform:
- Generates and tests drug-disease hypotheses by synthesising fragmented evidence
- Reconciles scientific claims and verifies their validity against current data
- Connections evidence trapped in disparate tools/teams, reducing friction and accelerate discovery
Already evidence of leapfrog impact: The engine successfully processed a disease’s entire literature, constructed a cohesive biological map, and produced drug-target hypotheses—each stamped with clear evidence trails (supported, refuted, and traceable).
We hit ground-running product/market-fit: current go-to-market focuses on integrated target validation, informing discovery teams on priority targets and their backing.
Look long-term to full-gamut drug discovery acceleration—predicting how a molecule and disease will interact before mid trial and explaining the findings.
Reasons to use Rodeo
Start with a chat, not a search bar
Grad scheme, placement, apprenticeship? Not sure what you want yet — that's fine. Your agent talks it through with you and turns "I have no idea" into a shortlist.
It searches the market for you
Every day your agent scans the market matching roles against what actually matters to you, not just keywords on a CV.
Only hits
No noise. No "maybe this fits." Just roles with a clear explanation of why they're right — and where to focus when applying.
A new economics for AI in Pharma
Our commercial model envisages fast industry adoption: chercheurs pay for expert insight (small upfront costs, milestone rewards)—aligned with pharma’s increasing monetised AI practices.
The Role
This is a hands-on operator role—starting day one you will co-own company-side leadership alongside two technical founders (architecting the product, science).
Core Responsibilities
-
Drive fundraising*:
- Lead our seed and Series A rounds—underwriting the most important input for our growth.
- Position DSV, question, audience, and clear path to scalable outcomes.
-
Build the commercial engine:
- Enter into partnerships, pilots, and secure paying pharma/biotech customers
- Connect with research institutions.
-
Scale the business:
- Hire focused team.
- Defend/expand company narrative.
- Engage with investors, grants, academic connections—maximizing ‘air cover’ for hiring.
-
Shape strategy & positioning:
- Adopt clear metaphors for market maximisation.
- Refine messaging and manage relations externally.
- Align with our technical visionary founders.
Location: Hybrid, UK-archetypal operation from spin-out Equity: Fully proportionate co-founder equity, highly future-rich as our milestones roll.
- Must: Personally fundraising that best represents you to the world; closing critical checkpoints.
Essential Values
- Frisson at building world-definitions: JP Morgan-analogue of ambition within healthcare.
- First-principles outcome thinking: Will they lose candidates here? Are pilots getting warmed up fast enough?
- Move-upfast; nuclear ambiguity: Irreducible complexity at the heart of building great healthcare ventures.
- Collaborative: Must pair tightly with two core founders.
Essential Experience (Non-Negotiable)
- Founding or C-suite experience (otherwise accession titles or roles not considered).
- Personal VC-raising experience—serious preferred lens—multiple regulated sole-pitched rounds (~£5M+/5).
- Network in deep-tech/AI/bio—proven to connect climate-lean seed investors and analysts.
- Demonstrable beating the odds in sales—fostered partnerships or sold directly to pharma/biotech.
- Referenceable Cognitive Bridging across scientific or methodological barriers i.e. uncaught worldwide names in Pharma congratulated by the same].
- Physical independence: Required to commit to UK-head full CEF timelines post-spinout.
Get help with your application
Your very own career expert that helps elevate your application to the next level.
Preferred Experience (Fine but not sublime)
- History at leading AI/research labs: beforehand facilitating large-scale outcomes found mutually.
- Scaled company from seed to Series A.
- Next-iteration Pharma Mastery: scaled network within pharma BD (enterprise or contractor).
- Successfully sold platform tools to high-friction ALP markets (Pharma, Biotech).
Why Join Deep Science Ventures (DSV)?
Deep Science Ventures backs an ultra-majestic propose for science and impact.
- A portfolio now worth ~$700 million (~50 companies served by our network/institutions).
- Proprietary venture-creation resources geared to startups from scratch—YC obverse meeting.
- Direct founder-type Grant/Academic BU network.
- Intra-perimoter any new funding rounds team/event-made (part of our appeal).
- Permanent Commercial MOL after spin-out:
- Hiring, partnerships, investor relations, scaling (tending by studio).
Company Equity, Milestone more as won
Lock-in tenure/individual incentive secondary hybrid equity-ownership.
Become Us
If you sincerely aspire to build at the vanguard of AI and drug discovery, and understand both the value of being entrepreneurial within rapid, subjective, yet well-networked construction, we’re waiting for your encompassing story.
“It took my CV and asked me questions relevant to understanding what kind of jobs to suggest for me. Suggestions were almost perfect. Jobs were exactly what I’ve been looking for.”
Jessica, London
Location